The FTC is moving to block this. It'll have to go through a court challenge. AMGEN and Horizons said that they remain committed to the deal, which means that they're willing to litigate this. The complaint is not yet unsealed. So we'll see a little bit more about some of the exact allegations.
Bloomberg Intelligence Senior Litigation Analyst, Jennifer Rie and Bloomberg Antitrust Reporter Leah Nylen discuss the latest with the FTC’s suit to block Amgen’s deal with Horizon Therapeutics. Mary Lou Gardner, Associate Partner for CPG, Retail and Logistics at Infosys Consulting discusses consumer outlook in retail. Bloomberg Businessweek Editor Joel Weber and Bloomberg Editorial Senior Commodities Reporter James Attwood discuss the green energy transition and Chile’s copper problem. And we Drive to the Close with Hank Smith, CIO of Haverford Trust.
Hosts: Carol Massar and Matt Miller. Producer: Sara Livezey
See omnystudio.com/listener for privacy information.